What Happened?
, -based Biolase Appointed Jennifer Bright as chief financial, operating officers
About the Company
Biolase is revolutionizing surgery in dentistry and medicine with WaterLase technology. We specialize in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients. Biolase leads the global dental industry with our flagship, best-selling laser systems such as the WaterLase iPlus™ and WaterLase MDX™, which both feature novel, patented laser technologies designed by Biolase`s R&D and clinical teams to perform dental and medical surgery, while dramatically reducing pain and improving clinical results. Our newest addition to our product lineup is the EPIC™ Total Diode Solution, which is loaded with one Biolase exclusive feature after another, including Laser Whitening and Pain Therapy. Our popular diode laser lineup is rounded out by the iLase™ Personal Diode Laser, the world`s first totally wireless handheld dental laser which is easily portable for dentists and hygienists. We also just entered the veterinary realm with the EPIC V™ Series, the only animal laser capable of delivering peak power and portability to handle dental soft tissue, surgery and pain therapy. Our vision for Biological Dentistry™ goes beyond lasers. With the rising popularity and clinical necessity of 3D imaging within dentistry, Biolase is at the forefront of these trends. Recently, Biolase was named the exclusive North American distributor for NewTom™ 3D Cone Beam imaging systems, which are considered among the world`s best for dentistry and medicine. Recently, we entered an agreement to distribute 3Shape TRIOS™, a groundbreaking digital intraoral scanner to capture fully digital, 3D impressions, an important step in millions of restorative procedures performed each year. Other products currently under development include further innovation in dental laser implementation, and future projects are addressing the booming markets of ophthalmology, dermatology, orthopedics, podiatry, and other medical and consumer markets.
About the Person
Jennifer Bright is chief financial, operating officers at Biolase. Previously, Jennifer held various senior HR leadership roles in the industry.
Info Source
News
Short Profile